Abstract
Cardiovascular diseases are the leading cause of mortality rates throughout the world. Next to an insufficient number of healthy donors, this has led to increasing numbers of patients on heart transplant waiting lists with prolonged waiting times. Innovative technological advancements have led to the production of ventricular assist devices that play an increasingly important role in end stage heart failure therapy. This review is intended to provide an overview of current implantable left ventricular assist devices, different design concepts and implantation techniques. Challenges such as infections and thromboembolic events that may occur during LVAD implantations have also been discussed.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Aissaoui N, Morshuis M, Maoulida H, Salem JE et al (2017) Management of end-stage heart failure patients with or without ventricular assist device: an observational comparison of clinical and economic outcomes. Eur J Cardiothorac Surg 53:170–177
Berlin Heart [Internet]. [cited 2016 Oct 24]. Available from http://www.berlinheart.de/index.php/mp/content/produkte
Birks EJ (2010) The comparative use of ventricular assist devices. Tex Heart Inst J 37(5):565–567
Camboni D, Zerdzitzki M, Hirt S, Tandler R, Weyand M, Schmid C (2016) Reduction of INCOR® driveline infection rate with silicone at the driveline exit site. Interact Cardiovasc Thorac Surg 24:222–228
Dean D, Kallel F, Ewald GA, Tatooles A, Sheridan BC, Brewer RJ et al (2015) Reduction in driveline infection rates: results from the HeartMate II multicenter driveline silicone skin interface (SSI) registry. J Heart Lung Transplant Off Publ Int Soc Heart Transplant 34(6):781–789
Der Deutsche Herzbericht [Internet]. [cited 2016 Oct 24]. Available from http://www.herzstiftung.de/herzbericht
Eurotransplant – Statistics [Internet]. [cited 2016 Oct 24]. Available from http://statistics.eurotransplant.org/
Fleissner F, Avsar M, Malehsa D, Strueber M, Haverich A, Schmitto JD (2013) Reduction of driveline infections through doubled driveline tunneling of left ventricular assist devices. Artif Organs 37(1):102–107
Frazier OH, Khalil HA, Benkowski RJ, Cohn WE (2010) Optimization of axial-pump pressure sensitivity for a continuous-flow total artificial heart. J Heart Lung Transplant Off Publ Int Soc Heart Transplant 29(6):687–691
Frazier OH, Baldwin ACW, Demirozu ZT, Segura AM, Hernandez R, Taegtmeyer H et al (2015) Ventricular reconditioning and pump explantation in patients supported by continuous-flow left ventricular assist devices. J Heart Lung Transplant 34(6):766–772
Geidl L, Zrunek P, Deckert Z, Zimpfer D, Sandner S, Wieselthaler G et al (2009) Usability and safety of ventricular assist devices: human factors and design aspects. Artif Organs 33(9):691–695
Girdhar G, Xenos M, Alemu Y, Chiu W-C, Lynch BE, Jesty J et al (2012) Device thrombogenicity emulation: a novel method for optimizing mechanical circulatory support device thromboresistance. PLoS One [Internet]. [cited 2016 Oct 24]; 7(3). Available from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3292570/
Hanke JS, Rojas SV, Avsar M, Haverich A, Schmitto JD (2015) Minimally-invasive LVAD implantation: state of the art. Curr Cardiol Rev 11(3):246–251
Hanke JS, Rojas SV, Poyanmehr R, Deniz E, Avsar M, Berliner D et al (2016a) Left ventricular assist device implantation with outflow graft tunneling through the transverse sinus. Artif Organs 40(6):610–612
Hanke JS, ElSherbini A, Rojas SV, Avsar M, Shrestha M, Schmitto JD (2016b) Aortic outflow graft stenting in patient with left ventricular assist device outflow graft thrombosis. Artif Organs 40(4):414–416
Heart Assist Devices – Texas Heart Institute [Internet]. [cited 2016 Oct 24]. Available from http://www.texasheart.org/Research/Devices/
Heart-Lung Machine HL 20 — Maquet [Internet]. [cited 2016 Oct 24]. Available from http://www.maquet.com/int/products/heart-lung-machine-hl-20/
HeartWare [Internet]. [cited 2016 Oct 24]. Available from https://www.heartware.com/
Jarvik Heart Inc. The Jarvik 2000 [Internet]. Jarvik Heart Inc. The Jarvik 2000. [cited 2016 Oct 24]. Available from http://www.jarvikheart.com/
johan.van.der.heide[at]itea3.org J van der H. 14003 Medolution [Internet]. itea3.org. [cited 2016 Oct 24]. Available from https://itea3.org/project/medolution.html
Khvilivitzky K, Mountis MM, Gonzalez-Stawinski GV (2012) Heartmate II outflow graft ligation and driveline excision without pump removal for left ventricular recovery. Proc Bayl Univ Med Cent 25(4):344–345
Kirklin JK, Naftel DC, Pagani FD, Kormos RL, Stevenson LW, Blume ED et al (2015) Seventh INTERMACS annual report: 15,000 patients and counting. J Heart Lung Transplant Off Publ Int Soc Heart Transplant 34(12):1495–1504
Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, Simone GD et al (2010) Heart disease and stroke statistics—2010 update. Circulation 121(7):e46–215
Loree HM, Bourque K, Gernes DB, Richardson JS, Poirier VL, Barletta N et al (2001) The Heartmate III: design and in vivo studies of a maglev centrifugal left ventricular assist device. Artif Organs 25(5):386–391
Mancini D, Colombo PC (2015) Left ventricular assist devices: a rapidly evolving alternative to transplant. J Am Coll Cardiol 65(23):2542–2555
Mehta SM, Pae WE, Rosenberg G, Snyder AJ, Weiss WJ, Lewis JP et al (2001) The LionHeart LVD-2000: a completely implanted left ventricular assist device for chronic circulatory support. Ann Thorac Surg 71(3 Suppl):S156–S161. discussion S183–184
Pagani FD, Miller LW, Russell SD, Aaronson KD, John R, Boyle AJ et al (2009) Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device. J Am Coll Cardiol 54(4):312–321
Reul HM, Akdis M (2000) Blood pumps for circulatory support. Perfusion 15(4):295–311
Rodriguez LE, Suarez EE, Loebe M, Bruckner BA (2013) Ventricular assist devices (VAD) therapy: new technology, new hope? Methodist Debakey Cardiovasc J 9(1):32–37
Sabashnikov A, Högerle BA, Mohite PN, Popov A-F, Sáez DG, Fatullayev J et al (2013) Successful bridge to recovery using two-stage HeartWare LVAD explantation approach after embolic stroke. J Cardiothorac Surg 8:233
Schmitto JD, Rojas SV, Hanke JS, Avsar M, Haverich A (2014) Minimally invasive left ventricular assist device explantation after cardiac recovery: surgical technical considerations. Artif Organs 38(6):507–510
Schmitto JD, Hanke JS, Rojas S, Avsar M, Malehsa D, Bara C et al (2015) Circulatory support exceeding five years with a continuous-flow left ventricular assist device for advanced heart failure patients. J Cardiothorac Surg 10:107
Schmitto JD, Pya Y, Zimpfer D, Krabatsch T, Garbade J, Rao V, et al. (2017) HeartMate 3 fully magnetically levitated left ventricular assist device for the treatment of advanced heart failure - CE mark study 2-year results. J Heart Lung Transplant 36(4):S66
Seco M, Zhao DF, Byrom MJ, Wilson MK, Vallely MP, Fraser JF, Bannon PG (2017) Long-term prognosis and cost-effectiveness of left ventricular assist device as bridge to transplantation: a systematic review. Int J Cardiol 235:22–32
Slaughter MS, Pagani FD, Rogers JG, Miller LW, Sun B, Russell SD et al (2010) Clinical management of continuous-flow left ventricular assist devices in advanced heart failure. J Heart Lung Transplant Off Publ Int Soc Heart Transplant 29(4 Suppl):S1–39
Tang DG, Oyer PE, Mallidi HR (2009) Ventricular assist devices: history, patient selection, and timing of therapy. J Cardiovasc Transl Res 2(2):159–167
Thoratec – Innovative Therapies for Advanced Heart Failure [Internet]. [cited 2016 Oct 24]. Available from http://www.thoratec.com/
U S Food and Drug Administration Home Page [Internet]. [cited 2016 Oct 24]. Available from http://www.fda.gov/
Welcome to Reliant Heart [Internet]. [cited 2016 Oct 24]. Available from http://reliantheart.com/
WHO|NCD mortality and morbidity [Internet]. WHO. [cited 2016 Oct 24]. Available from http://www.who.int/gho/ncd/mortality_morbidity/en/
Wieselthaler GM, O Driscoll G, Jansz P, Khaghani A, Strueber M, HVAD Clinical Investigators (2010) Initial clinical experience with a novel left ventricular assist device with a magnetically levitated rotor in a multi-institutional trial. J Heart Lung Transplant Off Publ Int Soc Heart Transplant 29(11):1218–1225
Wilkins E, Wilson L, Wickramasinghe K, Bhatnagar P, Leal J, Luengo-Fernandez R, Burns R, Rayner M, Townsend N (2017) European cardiovascular disease statistics 2017. European Heart Network, Brussels
Zucchetta F, Tarzia V, Bottio T, Gerosa G (2014) The Jarvik-2000 ventricular assist device implantation: how we do it. Ann Cardiothorac Surg 3(5):525–531
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG
About this chapter
Cite this chapter
Feldmann, C., Chatterjee, A., Haverich, A., Schmitto, J.D. (2018). Left Ventricular Assist Devices – A State of the Art Review. In: Islam, M. (eds) Heart Failure: From Research to Clinical Practice. Advances in Experimental Medicine and Biology(), vol 1067. Springer, Cham. https://doi.org/10.1007/5584_2018_145
Download citation
DOI: https://doi.org/10.1007/5584_2018_145
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-78279-9
Online ISBN: 978-3-319-78280-5
eBook Packages: MedicineMedicine (R0)